"At Fred Hutch, our interdisciplinary teams conduct high-impact science to achieve our mission: eliminating cancer and related diseases as causes of human suffering and death through prevention and curative treatments that are accessible to all patients."

During the past decade, Seattle Cancer Care Alliance conducted 323 clinical trials. In the 10-year time frame, 323 clinical trials started and 201 clinical trials were completed, i.e. on average, 62.2% percent of trials that started reached the finish line to date. In the past 5 years, 122 clinical trials started and 127 clinical trials were completed. i.e. 104.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Seattle Cancer Care Alliance" #1 sponsor was "Pfizer" with 43 trials, followed by "Bristol-Myers Squibb" with 28 trials sponsored, "University of Washington" with 22 trials sponsored, "National Cancer Institute (NCI)" with 19 trials sponsored and "SWOG Cancer Research Network" with 19 trials sponsored. Other sponsors include 431 different institutions and companies that sponsored additional 198 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Seattle Cancer Care Alliance" #1 collaborator was "National Cancer Institute (NCI)" with 87 trials as a collaborator, "Merck Sharp & Dohme LLC" with 18 trials as a collaborator, "Bristol-Myers Squibb" with 12 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator and "Canadian Cancer Trials Group" with 7 trials as a collaborator. Other collaborators include 165 different institutions and companies that were collaborators in the rest 126 trials.

According to Clinical.Site data, the most researched conditions in "Seattle Cancer Care Alliance" are "Prostate Cancer" (34 trials), "Breast Cancer" (28 trials), "Melanoma" (25 trials), "Colorectal Cancer" (16 trials) and "Non-Small Cell Lung Cancer" (15 trials). Many other conditions were trialed in "Seattle Cancer Care Alliance" in a lesser frequency.

Most popular intervention types in "Seattle Cancer Care Alliance" are "Drug" (470 trials), "Biological" (109 trials), "Other" (78 trials), "Procedure" (37 trials) and "Radiation" (28 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (41 trials), "Laboratory Biomarker Analysis" (37 trials), "Nivolumab" (26 trials), "Paclitaxel" (23 trials) and "Pembrolizumab" (23 trials). Other intervention names were less common.

The vast majority of trials in "Seattle Cancer Care Alliance" are 451 trials for "All" genders, 60 trials for "Female" genders and 55 trials for "Male" genders.

Currently, there are 202 active trials in "Seattle Cancer Care Alliance". 1 are not yet recruiting, 77 are recruiting, 123 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 254 completed trials in Seattle Cancer Care Alliance, undefined suspended trials, and 92 terminated clinical trials to date.

Out of the total trials that were conducted in Seattle Cancer Care Alliance, 178 "Phase 1" clinical trials were conducted, 287 "Phase 2" clinical trials and 139 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 14 trials that are defined as “Not Applicable".

Seattle Cancer Care Alliance has several departments that took part in Clinical trials: "Seattle Cancer Care Alliance at EvergreenHealth" - 54 trials, "Peninsula Cancer Center" - 45 trials, "Seattle Cancer Care Alliance/University of Washington Medical Center" - 11 trials